Recombinant Human MIG (CXCL9)
Catalog Number : 300-26
MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines.
Above 98% as determined by SDS-PAGE Analysis.
Determined by its ability to chemoattract human peripheral blood T lymphocytes using a concentration range of 10.0-100.0 ng/ml.
TPVVRKGRC SCISTNQGT IHLQSLKDL KQFAPSPSC EKIEIIATL KNGVQTCLN PDSADVKEL IKKWEKQVS QKKKQKNGK KHQKKKVLK VRKSQRSRQ KKTT
|Research Interest:||Innate Immunity, Angiogenesis, Inflammation|
|Cell Type:||Macrophage / Monocyte|
|Protein Cross Reactivity:||NULL|